Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Industry
Chinese hospital market scale is nearly 300 billion yuan2009-12-07
Bayer's Betaferon gets Chinese approval to treat MS2009-12-04
Venture capitalists funding more bio-pharmaceutical projects in China2009-12-03
Roche takes most China's hepatitis C market2009-12-02
Catalogue of Medical Insurance (2009 edition) issued2009-12-01
China's government to strengthen supervision for Vitamin C industry2009-11-30
Shanghai Biolaxy wins IND for oral insulin  in China2009-11-27
GSK won commercialization right of Viread in China2009-11-27
Sales value of medicine in China will be 46nbsp;bn2009-11-25
Tarceva's market share caught up with Iressa in China2009-11-24
GSK may shift some Relenza manufacturing to mainland2009-11-19
Chengdu biopharmaceutical industry aims 90 bn by 20122009-11-17
Tianyao finished the technology improvement of Androstenedione2009-11-16
JiLin Paigao got clinical trial approval for Clofarabine2009-11-11
Wanbang Biopharma with D-Pharm to develop DP-b99 in China2009-11-11
Ciclesonide Powder Inhalants listed in New Drug Creation Program2009-11-10
Market capacity of Chinese drugstores is 66 bn in the first half year2009-11-09
Beijing bio-pharm industry appears booming trend2009-11-09
Novartis to buy majority stake of Zhejiang Tianyuan2009-11-05
Novartis to invest  times="32".25 bn on China R&D centers2009-11-05
Novo Nordisk to expand R&D presence in China2009-11-04
The third largest research centre settled China2009-11-03
DSM suspends the contracts with NCPC in China2009-11-03
Medical reform created big instruments demand2009-11-02
Simcere collaborates with OSI Pharma to develop OSI-9302009-11-02
Sanofi-Aventis to build a JV focusing on vitamin medicines in China2009-10-30
Microbix and Chinese company to build Asia's largest flu vaccine facility2009-10-29
Gross output value of Chinese pharma. industry to be 1000 bn in 20092009-10-28
Sanhome's levo-ornidazole Nacl injection approved by SFDA2009-10-26
Compilation of China Pharmacopoeia (2010 Edition) finished2009-10-23
Guided retail prices of essential medicine implemented since Oct. 222009-10-23
New TCM standard created2009-10-22
共1471个 页次:32/46页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463